## **Core Concept**
The management of upper gastrointestinal bleeding (UGIB) involves stabilization of the patient, assessment of the severity of bleeding, and early endoscopic evaluation to determine the cause and control the bleeding. In a patient with a known duodenal ulcer on H2 blocker therapy, the likely cause of UGIB is ulcer bleeding.

## **Why the Correct Answer is Right**
The correct approach involves discontinuing the H2 blocker or switching to a proton pump inhibitor (PPI) because PPIs are more effective in reducing gastric acid secretion, which helps in clot stabilization and ulcer healing. Endoscopic evaluation is crucial for identifying the source of bleeding and possibly applying endoscopic treatments to control bleeding. Therefore, the next step after blood replacement is to prepare for or perform an endoscopy.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because simply continuing or changing the antisecretory therapy without investigating the source of bleeding is inadequate.
- **Option B:** This option might seem plausible but does not directly address the immediate need for endoscopic evaluation and treatment, which is critical in the management of UGIB.
- **Option C:** This option is incorrect because, although blood transfusion is important, the next step after beginning blood replacement should focus on identifying and treating the cause of bleeding.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that in the setting of UGIB, early endoscopic evaluation (within 24 hours of admission) is recommended for patients who are hemodynamically unstable or have signs of severe bleeding. The use of PPIs is preferred over H2 blockers in this setting due to their potent acid-suppressing effects, which facilitate clot stabilization.

## **Correct Answer:** .